je.st
news
Tag: lung
Study estimates 6% of lung cancer deaths in US and UK attributable to diesel exhaust
2013-11-28 15:30:15| Green Car Congress
Tags: to
study
cancer
estimates
Diesel Responsible for 6 Percent of Lung Cancer Deaths: Study
2013-11-27 06:00:00| Climate Ark Climate Change & Global Warming Newsfeed
Environmental Health News: An estimated 6 percent of lung cancer deaths in the United States and the United Kingdom 11,000 deaths per year may be due to diesel exhaust, according to a new study. Emission standards for diesel engines have become more stringent in recent years, but their exhaust still plays a significant role in lung cancer deaths among truckers, miners and railroad workers, the authors wrote. In addition, diesel exhaust still poses a major cancer threat for people living in dense cities or near highways,...
Tags: study
responsible
percent
cancer
A Chinese Childs Lung Cancer Is Linked to Pollution
2013-11-08 22:02:00| Climate Ark Climate Change & Global Warming Newsfeed
National Geographic: An eight-year-old girl, living near a major road in the Jiangsu Province of Eastern China, has become the youngest person in China, and possibly in the world, to be diagnosed with lung cancer caused by pollution-the cause of her disease according to Chinese officials. And last month, the World Health Organization classified air pollution as a major human carcinogen. We talked with C. Arden Pope, economics professor at Brigham Young University in Provo, Utah. His research into the effects of air...
Tags: to
chinese
cancer
linked
SOLIAIR - New Respiratory And Lung Diseases Drug Discovery Released
2013-10-30 05:07:22| drugdiscoveryonline News Articles
SOLIAIR is a blend of botanical extracts and a food supplement that contains a unique composition of ingredients, which has reported beneficial impact
Tags: drug
released
discovery
diseases
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer
2013-10-29 06:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Phase II/III Trial of MK-3475 in Patients with NSCLC Currently Enrolling WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Language: English Contact: MerckMedia Contacts:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestor Contacts:Carol Ferguson, 908-500-1101orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »